key: cord-0978767-wimsktta
authors: Kashir, Junaid; Yaqinuddin, Ahmed
title: Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19
date: 2020-04-25
journal: Med Hypotheses
DOI: 10.1016/j.mehy.2020.109786
sha: caff1d8219b57b6ed9ca6be083d4e7e1a0fd977d
doc_id: 978767
cord_uid: wimsktta

Abstract Recently, a novel coronavirus (SARS-CoV-2; coronavirus disease 2019, COVID-19) has emerged, rapidly spreading and severely straining the capacity of the global health community. Many nations are employing combinations of containment and mitigation strategies, where early diagnosis of COVID-19 is vital in controlling illness progression and limiting viral spread within the population. Thus, rapid and accurate methods of early detection are vital to contain COVID-19 and prevent further spread and predicted subsequent infectious waves of viral recurrence in future. Immediately after its initial characterization, Chinese and American Centers for Disease Control and Prevention (CDCs) rapidly employed molecular assays for detection of COVID-19, mostly employing real-time polymerase chain reaction (RT-PCR) methods. However, such methods require specific expensive items of equipment and highly trained analysts, requiring upwards of 4-8 hours to process. These requirements coupled with associated financial pressures may prevent effective deployment of such diagnostic tests. Loop mediated isothermal amplification(LAMP) is method of nucleic acid amplification which exhibits increased sensitivity and specificity are significantly rapid, and do not require expensive reagents or instruments, which aids in cost reduction for coronavirus detection. Studies have shown the successful application of LAMP assays in various forms to detect coronavirus RNA in patient samples, demonstrating that 1-10 copies of viral RNA template per reaction are sufficient for successful detection, ∼100-fold more sensitive than conventional RT-PCR methods. Importantly, studies have also now demonstrated the effectiveness of LAMP methodology in the detection of SARS-CoV-2 RNA at significantly low levels, particularly following numerous improvements to LAMP assay protocols. We hypothesise that recent advancements in enhanced LAMP protocols assay perhaps represent the best chance for a rapid and robust assay for field diagnosis of COVID-19, without the requirement of specialized equipment and highly trained professionals to interpret results. Herein, we present our arguments with a view to disseminate such findings, to assist the combat of this virus that is proving so devastating. We hope that this strategy could be applied rapidly, and confirmed for viability with clinical samples, before being rolled out for mass-diagnostic testing in these current times.

Recently, a novel coronavirus (SARS-CoV-2; coronavirus disease 2019, COVID-19) has emerged, rapidly spreading and severely straining the capacity of the global health community.

Many nations are employing combinations of containment and mitigation strategies, where early diagnosis of COVID-19 is vital in controlling illness progression and limiting viral spread within the population. Thus, rapid and accurate methods of early detection are vital to contain COVID-19 and prevent further spread and predicted subsequent infectious waves of viral recurrence in future. Immediately after its initial characterization, Chinese and American Centers for Disease Control and Prevention (CDCs) rapidly employed molecular assays for detection of COVID-19, mostly employing real-time polymerase chain reaction (RT-PCR) methods. However, such methods require specific expensive items of equipment and highly trained analysts, requiring upwards of 4-8 hours to process. These requirements coupled with associated financial pressures may prevent effective deployment of such diagnostic tests. Loop mediated isothermal amplification (LAMP) is method of nucleic acid amplification which exhibits increased sensitivity and specificity are significantly rapid, and do not require expensive reagents or instruments, which aids in cost reduction for coronavirus detection.

Studies have shown the successful application of LAMP assays in various forms to detect coronavirus RNA in patient samples, demonstrating that 1-10 copies of viral RNA template per reaction are sufficient for successful detection, ~100-fold more sensitive than conventional RT-PCR methods. Importantly, studies have also now demonstrated the effectiveness of LAMP methodology in the detection of SARS-CoV-2 RNA at significantly low levels, particularly following numerous improvements to LAMP assay protocols. We hypothesise that recent advancements in enhanced LAMP protocols assay perhaps represent the best chance for a rapid and robust assay for field diagnosis of COVID-19, without the requirement of specialized equipment and highly trained professionals to interpret results. Herein, we present [2] . However, early diagnosis of COVID-19 is vital in controlling illness progression and limiting viral spread within the population, employed as part of such mitigation strategies to stop onward transmission and decrease load on healthcare systems [3, 4] .

Thus, rapid and accurate methods of early detection are vital to contain COVID-19, and prevent further spread and predicted subsequent infectious waves of viral recurrence in future ( Figure 1 ). Although COVID-19 is generally thought to be milder compared to SARS and MERS-CoV, the full extent of the impact from COVID-19 remains pending. However, this outbreak represents an opportunity for multiple governmental and health sector stakeholders to partner and develop rapid diagnostic tests for infectious agents of global health concern [5] .

To enable effective identification and isolation strategies, a rapid and robust diagnostic test is essential, conductible in the field and at local point-of-care (POC) centres, without the requirement of specialized equipment and highly trained professionals to interpret results.

Herein, we propose from a collection of recently published articles a potential protocol based on loop mediated isothermal amplification (LAMP).

and Prevention (CDCs) rapidly employed molecular assays for detection of COVID-19 in clinical samples [5] [6] [7] . These, and methods by other groups, mostly employed development of of quantitative RT-PCR characterized by rapid detection, high sensitivity and specificity, and are often described as a gold standard for virus detection [3] . However, further novel PCRbased methods also present enhanced specificity and assay sensitivity.

PCR produces numerous copies (amplification) of a gene or series of genetic sequences by using a primer sequence and DNA polymerase enzymes to exponentially increase the amount of DNA required. PCR is widely used to amplify minute quantities of DNA to enable adequate requisite amounts for laboratory analysis of diagnosis. Owing to its simplicity, high sensitivity, and high sequence specificity, PCR-based method are a routine and reliable method for detecting coronavirus infection in patients [3, 11, 12] . In principle, such assays are employed following conversion of coronavirus RNA into complementary DNA by reverse transcription, following which PCR is performed and resultant amplification of DNA subject to specific detection or analytical methods such as electrophoresis or sequencing [3, 13, 14] .

RT-PCR is significantly more sensitive than conventional methods [15, 16] , and is routinely employed as the predominant method to detection most coronaviruses [17, 18] , including COVID-19 [19] . A concern, however, particularly in the current demanding times, is that such analysis requires various specialist and expensive items of equipment, alongside highly trained analysts. Furthermore, current PCR-based methods of analysis require (realistically speaking, particularly when dealing with increasing volumes of potential infected) upwards of 4-8 hours to process. These requirements, with the addition of financial pressures dictating that samples to be tested be sent potentially hundreds of miles away where requisite facilities and resources are present to perform such diagnostic analysis, may result in further inflation of the required time and finances to perform such diagnostic tests.

Loop mediated isothermal amplification (LAMP) is a novel isothermal nucleic acid amplification method. LAMP exhibits increased sensitivity and specificity due to an exponential amplification feature that utilises 6 different target sequences simultaneously identified by separate distinct primers in the same reaction [20] . LAMP assays are significantly rapid, and do not require expensive reagents or instruments, which aids in cost reduction for coronavirus detection [3] . First, FIP anneals to the template, and extension occurs using a polymerase with displacement activity (such as Bst polymerase), which will displace the product obtained from FIP by the extension reaction associated with the F3 primer. Subsequently, an extension reaction occurs using BIP on the product of FIP, and not on the template DNA due to displacement by DNA synthesis associated with the B3 primer. These reactions result in a product with a dumbbell-like structure which is essential for LAMP to establish isothermal amplification as the loop structures are always single stranded and can be annealed by FIP or BIP. This loop structure formation eliminates the denaturing step, which is otherwise essential in PCR for obtaining single-stranded DNA, and also establishes a cyclic reaction between the dumbbell-like structure and its complementary product, leading to elongated products with various copies of the target sequence produced (for reviews and detailed schematics, refer to [22, 23] ).

Numerous studies have now shown the successful application of LAMP assays in various forms to detect coronavirus RNA in patients samples [24] [25] [26] [27] , demonstrating that 1-10 copies of viral RNA template per reaction was sufficient for successful detection, which were ~100fold more sensitive than conventional RT-PCR methods [26] [27] [28] [29] [30] [31] . Of course, however, as with any emerging technology, there are some disadvantages associated with LAMP assays. Such methodology prevents inclusion of an internal PCR inhibition control, necessitating duplication of reactions while testing. Another disadvantage is the perceived complexity of the methodology, requiring a complex primer design system which can constrain target site selection and resolution or specificity. Furthermore, as the final product is a large fragment, downstream applications such as cloning are limited.

However, despite such drawbacks, LAMP is an ultrasensitive nucleic acid amplification method that can detect minute quantities of DNA or RNA templates within roughly an hour, far outstripping normally utilised RT-PCR methods, particularly with the current demands for rapid and sensitive testing. As the growing number of suspected COVID-19 cases exceeds the capacity of many hospitals, many patients remain untested impeding efforts to the control the disease. A rapid, point-of-care diagnostic for the COVID-19 is urgently needed, which we propose to be the LAMP method of detection ( Table 1 ).

El-Tholoth et al., [32] recently described design of a two stage LAMP (COVID-19 Penn-RAMP) strategy, which could be carried out in closed tubes with either fluorescence or colorimetric detection. Performance of such assays were not only comparable with conventional RT-PCR assays, but also exhibited ~10-fold higher sensitivity when testing Tested on patient samples Less tested on patient samples Importantly, however, Zhang et al., [34] have described the successful application of LAMP methodology to identify COVID-19 viral RNA from purified RNA or patient cell lysis using a visual, colorimetric detection. These results were further verified using RNA samples purified from respiratory swabs collected from COVID-19 patients in Wuhan, China with performance comparable to commercial RT-PCR tests, requiring only heating and visual inspection. Intriguingly, results obtained were also comparable between 'spiked' RNA samples and patient samples, suggesting that the improved methodology of El-Tholoth et al., [32] should yield satisfactory results with patient samples (Figure 2 ). 

Considering the success obtained by Zhang et al., [34] using relatively less-sensitive LAMP, the enhanced sensitivity of the Penn-RAMP strategy employed by El-Tholoth et al., [32] attributable to a modified two-step LAMP protocol could prove significantly successful as a diagnostic. Penn-RAMP involves a preliminary reaction with outer LAMP primers to amplify all targets through recombinase polymerase amplification (RPA), in which all targets are amplified concurrently. After this, a second highly specific LAMP reaction is initiated.

Specifically, the first stage uses outer LAMP primers F3 and B3, while the second stage further combines the other 4 RAMP primers. This 'nested' principle significantly enhanced LAMP sensitivity by ~10-100-fold compared to normal LAMP, particularly when operating with purified and crude samples [35] . Indeed, the Penn-RAMP methodology when applied on mock trials by El-Tholoth et al., [32] provided a success rate of 100% at 7-10 copies of viral RNA per reaction, compared to a 100% success rate at 700 viral RNA copies required for PCR methods [32, 35] . To this degree, we hypothesise that the modified LAMP assay proposed by El-Tholoth et al., [32] perhaps represent the best chance for a rapid and robust assay for field diagnosis of COVID-19 (Figure 3 ), using the primer sequence strategies utilised ( We hypothesise that this assay is will be a rapid, cost-effective, and simple method that could be applied within the field at short-notice and utilised by users with even limited training.

All the equipment that would be required would be a hot-block or heater capable of differential heating. Reagent-wise, the costs would be similar to that of real time RT-PCR, but the real advantage of this would be the rapidity of this assay, yielding results within an hour of testing, compared to 4-8 hours taken with RT-PCR methods. The aim is not necessarily a quantitative measure of infection, but rather a simple positive/negative assay for rapid detection/confirmation. We consider that this strategy should be applied rapidly, and confirmed for viability with clinical samples, before being rolled out for mass-diagnostic testing in these current times. 

WHO Strategic and Technical Advisory Group for Infectious Hazards. COVID-19: towards controlling of a pandemic

Recent advances and perspectives of nucleic acid detection for coronavirus

WHO Coronavirus disease (COVID-2019) situation reports. Situation report-55

Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak

China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China

Washington State 2019-nCoV Case Investigation Team. First case of 2019 novel coronavirus in the United States

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia

A real-time PCR assay for bat SARS-like coronavirus detection and its application to Italian greater horseshoe bat faecal sample surveys

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

Comprehensive detection and identification of human coronaviruses, including the SARSassociated coronavirus, with a single RT-PCR assay

Detection of multiple viral sequences in the respiratory tract samples of suspected Middle East respiratory syndrome coronavirus patients in Jakarta

A Melting Curve-Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses

Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR. Simultaneous detection of severe acute respiratory syndrArch Virol

Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR

Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Loop-mediated isothermal amplification of DNA

Accelerated reaction by loop-mediated isothermal amplification using loop primers

Loop-Mediated Isothermal Amplification: An Advanced Method for the Detection of Giardia, Current Topics in Giardiasis

Novel Molecular Diagnostic Platform for Tropical Infectious Diseases, Current Topics in Tropical Medicine

Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loopmediated isothermal amplification assay

Development of loop-mediated isothermal amplification assay for detection of human coronavirus-NL63

Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation

Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)

Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus

Loop-mediated isothermal amplification technology: towards point of care diagnostics

Development of fluorescent reverse transcription loop-mediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus

A Rapid and Specific Assay for the Detection of MERS-CoV

Two-Stage Isothermal Enzymatic Amplification for Concurrent Multiplex Molecular Detection

Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics

The manuscript was conceived and written by both JK and AY, and submitted following approval of both authors

The authors report no conflict of interest